fbpx

OptiNose Inc

OPTN

$0.50

Closing

▼-3.86%

1D

▼-61.24%

YTD

OPTN

BBG00HS39GY3

Exchange

Sector

Market cap

$75.41M

Volume

144,482

Check if the stock is halal

Unlock Industry-grade Shariah Compliance for global stocks. See results from 5 major Shariah standards: AAOIFI, S&P, DJIM, FTSE and MSCI.

We provide unparalleled value and service.
Screened by AAOIFI Certified Shariah Advisor & Auditor.

Get started from just $6.99/month

Market cap

$75.41M

Analysts' Rating

BUY

Price Target (Mean)

3.50

Total Analysts

4

P/E

Operating Margin

-31.96%

Beta

-0.17

Revenue Growth

5.33%

52 week high

$2.10

52 week low

$0.33

Div. Yield

%

EPS Growth

-58.08

Company Profile

OptiNose, Inc. is a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists. The Company’s product, XHANCE (fluticasone propionate) nasal spray, 93 microgram (mcg), is a therapeutic utilizing its Exhalation Delivery System (EDS) that delivers a topically-acting corticosteroid for the treatment of chronic rhinosinusitis with nasal polyps and chronic rhinosinusitis without nasal polyps (also known as chronic sinusitis). XHANCE combines the EDS with a liquid formulation of fluticasone propionate, a well-characterized, second-generation corticosteroid. XHANCE is designed to deliver medication into the high and deep regions of the nasal passages where both nasal polyps and inflamed and swollen membranes can obstruct normal sinus ventilation and drainage. The Company has developed both a liquid delivery EDS and a powder delivery EDS utilizing natural functional behaviors of the upper nasal airways intended to offer better drug deposition.